Coloplast Still Pricey Even As A High-Quality Med-Tech Growth Name
Analysis of Coloplast's growth potential and concerns for Q1'25, including margin misses and slow share growth in the U.S.
AOTI, Inc. Accelerates Expansion in High-Value Wound Care Market
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Hemostemix stock takes off after amended manufacturing deal
Hemostemix (TSXV:HEM), a stem cell therapy stock, is up substantially after amending its manufacturing services agreement ...
Hemostemix Inc.: Hemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate ...
Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) is pleased to announce amendments to its Manufacturing Services Agreement with CytoImmune Therapeutics ...